Stability Indicating RP-HPLC Method for the Analysis of Dacomitinib and its Related Impurities in Bulk and Oral Solid Dosage Formulations
Venu Kamani, M. Sujatha, G. S. N. Koteswara Rao & N. Vinod Kumar · Journal of Pharmaceutical Research International · 2021
Dacomitinib is an epidermal growth factor receptor inhibitor prescribed for the treatment of metastatic non small-cell lung carcinoma. There are no reported significant official of HPLC methods that resolve the impurities and degradation products generated during stability studie...
Open access
Research Article
10.9734/jpri/2021/v33i40B32278